anti-inflammatory agent (Bio Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameanti-inflammatory agent (Bio Therapeutics)
Drug Alias Namelanthionine synthetase component C-like 2 modulators (BioTherapeutics)LANCL2 modulators (BioTherapeutics)61610
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanC-like protein 2 modulators
TargetsLanC-like protein 2
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio Therapeutics
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A